U.S. Biomedical Advanced Research and Development Authority (BARDA) Taps ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial

Saved in:
Bibliographic Details
Published inBenzinga Newswires
Format Newsletter
LanguageEnglish
Published Southfield Accretive Capital LLC d/b/a Benzinga 13.09.2023
Online AccessGet full text

Cover

More Information
Description not available.